SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-100740
Filing Date
2019-04-08
Accepted
2019-04-08 16:24:34
Documents
3
Effectiveness Date
2019-04-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A d709298ddefa14a.htm DEFA14A 20135
2 GRAPHIC g709298g0408074401448.jpg GRAPHIC 2751
3 GRAPHIC g709298g0408074401526.jpg GRAPHIC 2638
  Complete submission text file 0001193125-19-100740.txt   28933
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36407 | Film No.: 19737667
SIC: 2834 Pharmaceutical Preparations